B-Cell Chronic Lymphocytic Leukemia

DBCOND0030547Hemic and Lymphatic DiseasesImmune System Diseases

B-Cell Chronic Lymphocytic Leukemia is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Leukemia, B-Cell, Chronic · B-Cell Chronic Lymphocytic Leukemia (B-CLL) · Lymphoma, Lymphoplasmacytoid, CLL · Lymphoplasmacytoid Lymphoma, CLL · B-Cell Leukemia, Chronic
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT045637ICD-10C91.1SNOMED CT154589005MedDRA10024295UMLSC0023434

What you can answer from here — as of October 25, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
155Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for B-Cell Chronic Lymphocytic Leukemia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In